Microbiota and irritable bowel syndrome;Flore et syndrome de l'intestin irritable.

Gastroenterologie Clinique et Biologique

Volumn 34, Issue SUPPL. 1, 2010, Pages

  Ducrotte P ^a  

^a HÔPITAL CHARLES NICOLLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL OVERGROWTH; BACTEROIDES; BIFIDOBACTERIACEAE; CAMPYLOBACTER ENTERITIS; COLON FLORA; COLONIC FERMENTATION; CONSTIPATION; DIARRHEA; ESCHERICHIA COLI; GASTROINTESTINAL INFECTION; GIARDIASIS; IMMUNE RESPONSE; INTESTINE BIOPSY; IRRITABLE COLON; METABOLISM; NONHUMAN; PATHOPHYSIOLOGY; SALMONELLOSIS; SHIGELLOSIS; COLON; DIET THERAPY; EVIDENCE BASED MEDICINE; HUMAN; INTESTINE MUCOSA; METAGENOME; MICROBIOLOGY; RISK FACTOR; SMALL INTESTINE;

COLON; EVIDENCE-BASED MEDICINE; HUMANS; INTESTINAL MUCOSA; INTESTINE, SMALL; IRRITABLE BOWEL SYNDROME; METAGENOME; RISK FACTORS;

EID: 77957348374     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(10)70021-X     Document Type: Article

References (28)

1. Longstreth G.F., Thompson W.G., Chey W.D., Houghton L.A., Mearin F., Spiller R.C. Functional bowel disorders. Gastroenterology 2006, 130:1480-1491.
2. Mertz H.R. Irritable bowel syndrome. N Engl J Med 2003, 349:2136-2146.
3. Camilleri M., Talley N.J. Pathophysiology as a basis for understanding symptom complexes and therapeutic targets. Neurogastroenterol Motil 2004, 16:135-142.
4. Barbara G., Stanghellini V., Brandi G., Cremon C., Di Nardo G., De Giorgio R., et al. Interactions between commensal bacteria and gut sensorimotor function in health and disease. Am J Gastroenterol 2005, 100:2560-2568.
5. Bourdu S., Dapoigny M., Chapuy E., Artigue F., Vasson M.P., Déchelotte P., et al. Rectal instillation of butyrate provides a novel clinically relevant model of non-inflammatory colonic hypersensitivity in rats. Gastroenterology 2005, 128:1996-2008.
6. King T.S., Elia M., Hunter J.O. Abnormal colonic fermentation in irritable bowel syndrome. Lancet 1998, 352:1187-1189.
7. Dear K.L., Elia M., Hunter J.O. Do interventions which reduce colonic bacterial fermentation improve symptoms of irritable bowel syndrome?. Dig Dis Sci 2005, 50:758-766.
8. Marshall J.K., Thabane M., Garg A.X., Clark W., Salvadori M., Collins S.M., et al. Incidence and epidemiology of irritable bowel syndrome after a large waterbone outbreak of bacterial dysentery. Gastroenterology 2006, 131:445-450.
9. Mearin F., Pérez-Oliveras M., Perelló A., Vinyet J., Ibañez A., Coderch J., et al. Dyspepsia and irritable bowel syndrome after a salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology 2005, 129:98-104.
10. Morken M.H., Lind R.A., Valeur J., Wilhelmsen I., Berstad A. Subjective health complaints and quality of life in patients with irritable bowel syndrome following Giardia lamblia infection: a case control study. Scand J Gastroenterol 2009, 44:308-313.
11. Thabane M., Kottachchi D.T., Marshall J.K. Systematic review and meta-analysis: the incidence and prognosis of postinfectious irritable bowel syndrome. Aliment Pharmacol Ther 2007, 26:535-544.
12. Spiller R., Garsed K. Infection, inflammation, and the irritable bowel syndrome. Dig Liv Dis 2009, 41:844-849.
13. Spiller R.C., Jenkins D., Thornley J.P., Hebden J.M., Wright T., Skinner M., et al. Increased rectal mucosal enteroendocrine cells. T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000, 47:804-811.
14. Lin H.C. Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome. JAMA 2004, 292:852-858.
15. Pimentel M., Chow E.J., Lin H.C. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. A double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2003, 98:412-419.
16. Pimentel M., Chatterjee S., Chow E.J., Park S., Kong Y. Neomycin improves constipation-predominant irritable bowel syndrome in a fashion that is dependent on the presence of methane gas: sub-analysis of a double-blind randomized controlled study. Dig Dis Sci 2006, 51:1297-1301.
17. Pimentel M., Park S., Mirocha J., Kane S.V., Kong Y. The effect of a nonabsorbed antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med 2006, 145:557-563.
18. Posserud I., Stotzer P.O., Björnsson E.S., Abrahamsson H., Simrén M. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007, 56:802-808.
19. Lupascu A., Gabrielli M., Lauritano E.C., Scarpellini E., Santoliquido A., Cammarota G., et al. Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence casecontrol study in irritable bowel syndrome. Aliment Pharmacol Ther 2005, 22:1157-1160.
20. Ford A.C., Spiegel B.M., Talley N.J., Moayyedi P. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2009, 7:1279-1286.
21. Balsari A., Ceccarelli A., Dubini F., Fesce E., Poli G. The fecal microbial population in the irritable bowel syndrome. Microbiologica 1982, 5:185-194.
22. Kassinen A., Krogius-Kurikka L., Mäkivuokko H., Rinttilä T., Paulin L., Corander J., et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007, 133:24-33.
23. Swidsinski A., Weber J., Loening-Baucke V., Hale L.P., Lochs H. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel diseases. J Clin Microbiol 2005, 43:3380-3389.
24. Di Stefano M., Miceli E., Missanelli A., Mazzocchi S., Tana P., Corazza G.R. Role of colonic fermentation in the perception of colonic distension in irritable bowel syndrome and functional bloating. Clin Gastroenterol Hepatol 2006, 4:1242-1247.
25. Vanhoutvin S.A., Troost F.J., Kilkens T.O., Lindsey P.J., Hamer H.M., Jonkers D.M., et al. The effects of butyrate enemas on visceral perception in healthy volunteers. Neurogastroenterol Motil 2009, 21. 952-e76.
26. Quigley E.M., Flourie B. Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date. Neurogastroenterol Motil 2007, 19:166-172.
27. Frissora C.L., Cash B.D. Review article: the role of antibiotics vs. conventional pharmaco-therapy in treating symptoms of irritable bowel syndrome. Aliment Pharmacol Ther 2007, 25:1271-1281.
28. Brenner D.M., Moeller M.J., Chey W.D., Schoenfeld P.S. The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. Am J Gastroenterol 2009, 104:1033-1049.